Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

DIRECTOR DEALINGS: GlaxoSmithKline Executive Reinvests Dividend

16th Jul 2014 17:08

LONDON (Alliance News) - Pharmaceutical giant GlaxoSmithKline PLC Wednesday said Patrick Vallance, president of pharmaceuticals research and development, purchased 157 shares at a price of 1564.7584 pence per share on July 11, following the re-investment of a dividend.

GlaxoSmithKline shares closed flat at 1,543.50 pence Wednesday.

By Rowena Harris-Doughty; rowenaharrisdoughty@alliancenews.com; @rharrisdoughty

Copyright 2014 Alliance News Limited. All Rights Reserved.


Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value9,023.81
Change10.82